02197.HK
Clover Biopharmaceuticals, Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.29
−0.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 1.66x
- PEG TTM
- —
- Price / book
- -1.73x
- Price / sales
- 3264.73x
- Price / cash flow
- -5.31x
Enterprise value
- Enterprise value
- HKD 1.5B
- EV / sales
- 3022.17x
- EV / EBITDA
- -5.10x
- EV / EBIT
- -4.66x
- Market cap
- HKD 1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026